GSDMD and pancreatic neoplasm: LCL161 18 is a pyrrolidine-thiazole-containing compound that triggers pyroptosis in pancreatic cancer, leukemia, and multiple myeloma cells by activating caspase-1 and GSDMD [106, 107].